SCHEMBL709226

SCHEMBL709226

O=S(=O)(O)CS(=O)(=O)OCCOS(=O)(=O)CS(=O)(=O)O

nearest known ligand 0.32

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CA1 P00915 6/20 0.32
CA2 P00918 6/20 0.32
CA9 Q16790 6/20 0.32
CA12 O43570 2/20 0.32
CA3 P07451 2/20 0.32
CA4 P22748 2/20 0.32
CA6 P23280 2/20 0.32
CA5A P35218 2/20 0.32
CA7 P43166 2/20 0.32
CA14 Q9ULX7 2/20 0.32
CA5B Q9Y2D0 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10417289 0.89 CA1 (0.40) CA1CA2CA9CA12CA3
SCHEMBL10417127 0.89 CA1 (0.46) CA1CA2CA9CA12CA3
SCHEMBL10418181 0.89 CA1 (0.46) CA1CA2CA9CA12CA3
SCHEMBL21076362 0.85 CA1 (0.46) CA1CA2CA9CA12CA3
SCHEMBL11026628 0.85 LMNA (0.40) CA1CA2CA9CA12CA3
SCHEMBL2571880 0.82
SCHEMBL29199666 0.79 CHRM5 (0.39)
SCHEMBL27907198 0.79 CA1 (0.55) CA1CA2CA9CA12CA3
SCHEMBL27890461 0.79 CA1 (0.55) CA1CA2CA9CA12CA3
SCHEMBL27890586 0.79 CA1 (0.55) CA1CA2CA9CA12CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3940843-B1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME NINGDE AMPEREX TECHNOLOGY LTD (CN) 2025-07-23 EP claimed
CN-119866565-A Electrochemical device and electronic device 宁德新能源科技有限公司 2025-04-22 CN claimed
EP-4456231-A1 ELECTROCHEMICAL APPARATUS AND ELECTRONIC APPARATUS Ningde Amperex Technology Limited (CN) 2024-10-30 EP claimed
US-20240356069-A1 ELECTROCHEMICAL APPARATUS AND ELECTRONIC APPARATUS NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-10-24 US claimed
US-20240266540-A1 ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE COMPRISING SAME NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-08-08 US claimed
EP-4411894-A1 ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE COMPRISING SAME Ningde Amperex Technology Limited (CN) 2024-08-07 EP claimed
WO-2024065431-A1 ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE 宁德新能源科技有限公司 2024-04-04 WO claimed
CN-113812027-B Electrolyte, electrochemical device and electronic device comprising same 宁德新能源科技有限公司 2024-03-08 CN claimed
US-11888120-B2 Electrolyte and electrochemical device comprising the same NINGDE AMPEREX TECHNOLOGY LIMITED (CN) 2024-01-30 US claimed
WO-2023123027-A1 ELECTROCHEMICAL APPARATUS AND ELECTRONIC APPARATUS 宁德新能源科技有限公司 2023-07-06 WO claimed
CN-115053362-A Electrochemical device and electronic device including the same 宁德新能源科技有限公司 2022-09-13 CN claimed
WO-2022116170-A1 ELECTROLYTE, AND ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE COMPRISING ELECTROLYTE 宁德新能源科技有限公司 2022-06-09 WO claimed
EP-3940843-A1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME Ningde Amperex Technology Limited (CN) 2022-01-19 EP claimed
CN-113812027-A Electrolyte, electrochemical device containing electrolyte and electronic device 宁德新能源科技有限公司 2021-12-17 CN claimed
US-20210313611-A1 Method of Electrochemical Energy Storage Device Construction SOUTH 8 TECHNOLOGIES, INC. 2021-10-07 US claimed
US-10777848-B2 Lithium ion secondary battery ENVISION AESC JAPAN LTD. (JP) 2020-09-15 US claimed
EP-3113273-B1 LITHIUM ION SECONDARY BATTERY AUTOMOTIVE ENERGY SUPPLY CORP (JP) 2019-03-13 EP claimed
EP-3113247-B1 LITHIUM ION SECONDARY BATTERY AUTOMOTIVE ENERGY SUPPLY CORP (JP) 2018-11-21 EP claimed
US-8124793-B2 Derivatives of ethylene methanedisulfonate as cancer chemotherapeutic agents CRONYN MARSHALL W (US) 2012-02-28 US claimed
US-20090176805-A1 DERIVATIVES OF ETHYLENE METHANEDISULFONATE AS CANCER CHEMOTHERAPEUTIC AGENTS CRONYN MARSHALL W 2009-07-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176805-A1 DERIVATIVES OF ETHYLENE METHANEDISULFONATE AS CANCER CHEMOTHERAPEUTIC AGENTS MGMT, ETV6, EI24 CA1 1613/4885CA2 3240/4885CA9 1280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.